1. Articles from Jesse Fried

    1-1 of 1
    1. Will Nasdaq’s Diversity Rules Harm Investors?

      Will Nasdaq’s Diversity Rules Harm Investors?

      In December 2020, Nasdaq asked the Securities and Exchange Commission (SEC) to approve new diversity rules. The aim is for Nasdaq-listed firms to have at least one director self-identifying as female and another self-identifying as an underrepresented minority or LGBTQ+. To avoid forced delisting, a firm must “diversify or explain”: either have two such diverse directors, or say why it does not. Nasdaq also wants firms to disclose every director’s self-identified race, gender, and LGBTQ+ status...

      Read Full Article
    1-1 of 1
  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics in the News

    1. (8 articles) Board of Directors
    2. (7 articles) Board
    3. (5 articles) Nasdaq
    4. (1 articles) Cohen
    5. (1 articles) SEC
    6. (1 articles) Rules
    7. (1 articles) Corporate Governance
    8. (1 articles) California
    9. (1 articles) Diversity
    10. (1 articles) minority
    11. (1 articles) shareholder value
    12. (1 articles) social justice
    13. (1 articles) Investors
    14. (1 articles) Eliav Barr
    15. (1 articles) Yoon Suk-yeol
    16. (1 articles) Silicon Valley Bank
    17. (1 articles) Samsung
    18. (1 articles) Management
    19. (1 articles) Bank
    20. (1 articles) Fintech
  3. Popular Articles

  4. Picture Gallery

    Will Nasdaq’s Diversity Rules Harm Investors? OneWater Marine Announces the Appointment of Steve Roy to its Board of Directors Max Reinhardt Joins SURE Retractors Inc. Board of Directors Synctera Adds FinTech and Banking Leader Yvette Butler to Board of Directors Veracyte Appoints Eliav Barr, M.D., to Its Board of Directors Leap Therapeutics' Board of Directors Member Dr. Monica Bertagnolli Appointed as the Director of the National Cancer Institute Viracta Therapeutics Appoints Jane Chung, R.Ph., to its Board of Directors MindMed Strengthens Board with Appointment of Two New Independent Directors ‘Today, You Can Walk Around Like You Own the Place’ Samsung’s De Facto Chief, Freed From Prison a Year Ago, Is Pardoned ValueAct Capital Reports 6.7% Stake in New York Times Shared Company Ownership May be the Missing Path to the American Dream